Jci_page_head_homepage_01 Jci_page_head_homepage_02
Mallika Ghosh, Hector Leonardo Aguila, Jason Michaud, Youxi Ai, Ming-Tao Wu, Annabrita Hemmes, Ari Ristimaki, Caiying Guo, Henry Furneaux, Timothy Hla
Published in Volume 119, Issue 12
J Clin Invest. 2009; 119(12):3530–3543 doi:10.1172/JCI38263
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 1
Deletion of Elavl1 in adult mice leads to lethality.

(A) Tamoxifen-induced Elavl1 disruption in Elavl1f/f/Rosa26Cre/ERT2 (Elavl1Δ/Δ) mice. A schematic representation of conditional Elavl1 gene locus is shown. Arrows indicate the position of PCR primers; open triangles indicate loxP sites; the filled triangle indicates Frt site; and filled boxes indicate exons. F1, forward 1; R1, reverse 1. (B) PCR analysis of genomic DNA from indicated organs of mice 4 days after tamoxifen administration indicates either floxed or Elavl1 deletion (Δ) or cre bands. SI, small intestine. (C) IB analysis of tissue extracts with HuR antibody from Elavl1f/f and Elavl1Δ/Δ mice, 3 days after tamoxifen treatment. The same blot was reprobed with a β-actin mouse mAb. S, spleen; T, thymus; C, colon; J, jejunum; I, ileum. (D) Weight loss monitored over a period of 10 days upon deletion of Elavl1. (n = 4; *P < 0.05). (E) Cachexic phenotype of Elavl1Δ/Δ mice observed 4 days after tamoxifen administration. (F) Kaplan-Meier survival curves of Elavl1f/f [n = 8] and Elavl1Δ/Δ [n = 10] mice after tamoxifen treatment (P < 0.01, Log-rank test). Arrows indicate 3 doses of tamoxifen administration in D and F.